Ann Arbor, MI20 Active Studies

Ankylosing Spondylitis Clinical Trials in Ann Arbor, MI

Find 20 actively recruiting ankylosing spondylitis clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

20
Active Trials
16
Sponsors
17,392
Enrolling

Recruiting Ankylosing Spondylitis Studies in Ann Arbor

About Ankylosing Spondylitis Clinical Trials in Ann Arbor

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 20 ankylosing spondylitis clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 17,392 participants. Research is being sponsored by National Cancer Institute (NCI), University of California, San Francisco, Duke University and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Ann Arbor — FAQ

Are there ankylosing spondylitis clinical trials in Ann Arbor?

Yes, there are 20 ankylosing spondylitis clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 20 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated October 3, 2026 from ClinicalTrials.gov